ZA841657B - Leukotriene antagonists - Google Patents

Leukotriene antagonists

Info

Publication number
ZA841657B
ZA841657B ZA841657A ZA841657A ZA841657B ZA 841657 B ZA841657 B ZA 841657B ZA 841657 A ZA841657 A ZA 841657A ZA 841657 A ZA841657 A ZA 841657A ZA 841657 B ZA841657 B ZA 841657B
Authority
ZA
South Africa
Prior art keywords
leukotriene antagonists
leukotriene
antagonists
Prior art date
Application number
ZA841657A
Other languages
English (en)
Inventor
John Gerald Gleason
Ralph Floyd Hall
Thomas Wen-Fu Ku
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of ZA841657B publication Critical patent/ZA841657B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Epoxy Compounds (AREA)
ZA841657A 1983-03-07 1984-03-06 Leukotriene antagonists ZA841657B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/472,772 US4533747A (en) 1983-03-07 1983-03-07 Leukotriene antagonists intermediates

Publications (1)

Publication Number Publication Date
ZA841657B true ZA841657B (en) 1984-12-24

Family

ID=23876881

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA841657A ZA841657B (en) 1983-03-07 1984-03-06 Leukotriene antagonists

Country Status (4)

Country Link
US (1) US4533747A (xx)
JP (1) JPS59175464A (xx)
CA (1) CA1228864A (xx)
ZA (1) ZA841657B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4988716A (en) * 1984-07-18 1991-01-29 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4889873A (en) * 1984-07-18 1989-12-26 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4798842A (en) * 1984-07-18 1989-01-17 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
US4758594A (en) * 1984-07-18 1988-07-19 Schering Corporation Inhibitors of slow reacting substance of anaphylaxis
FI864901A (fi) * 1985-12-06 1987-06-07 Ciba Geigy Ag Hydroxitioetrar.
US4957281A (en) * 1989-01-30 1990-09-18 Wright State University Rotator cuff therapeutic exercise apparatus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873624A (en) * 1973-01-30 1975-03-25 Allied Chem Process of preparing {60 -formyl sulfides and 2-hydrocarbyl-thioaldoximes therefrom
US4177277A (en) * 1977-01-17 1979-12-04 E. R. Squibb & Sons, Inc. Method for alleviating hypertension
US4130713A (en) * 1977-08-05 1978-12-19 Hoffmann-La Roche Inc. Biotin intermediates

Also Published As

Publication number Publication date
JPS59175464A (ja) 1984-10-04
US4533747A (en) 1985-08-06
CA1228864A (en) 1987-11-03

Similar Documents

Publication Publication Date Title
EG16819A (en) Leukotriene antagonists
ZA882421B (en) Leukotriene antagonists
PH23051A (en) Srs-a antagonists
GR80846B (en) Substituted i-amino-4-nitro-acridinones
EP0140684A3 (en) Leukotriene antagonists
PH21573A (en) Substituted indeno-pyridazinones
GB8414912D0 (en) Substituted metaaminophenols
PT75955A (en) Lr-rh antagonists
DE3467173D1 (en) Lh- rh antagonists
DE3464903D1 (en) Leukotriene antagonists
GB8400173D0 (en) Substituted 4-amino-3-nitrophenols
PT78196A (en) Leukotriene antagonists
ZA874486B (en) Leukotriene antagonists
ZA841657B (en) Leukotriene antagonists
GB8413741D0 (en) Substituted acylipiperazinoquinazoles
GB2144121B (en) Substituted 3-hydrazinopropionates
DE3560717D1 (en) Leukotriene antagonists
ZA846154B (en) Lh-rh antagonists
IE850119L (en) Leukotriene antagonists
ZA85419B (en) Leukotriene antagonists
IE861606L (en) Leukotriene antagonists
IE872915L (en) Leukotriene antagonists
IE871656L (en) Leukotriene antagonists
IE851498L (en) Leukotriene antagonists
AU93563S (en) Collar